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Comprehensive proteomic 
investigation of infectious 
and inflammatory changes 
in late preterm prelabour rupture 
of membranes
Marie Vajrychová1*, Jaroslav Stráník2, Kristýna Pimková1,12, Malin Barman3, Rudolf Kukla4, 
Petra Zedníková1,5,13, Radka Bolehovská4, Lenka Plíšková6, Helena Hornychová7, 
Ctirad Andrýs8, Vojtěch Tambor1, Juraj Lenčo1,9, Bo Jacobsson10,11 & Marian Kacerovský1,2*
Preterm prelabour rupture of membranes beyond the 34th week of gestation (late PPROM) is 
frequently associated with the risk of the microbial invasion of the amniotic fluid (MIAC) and 
histological chorioamnionitis (HCA). Hence, we employed a Tandem Mass Tag-based approach to 
uncover amniotic fluid proteome response to the presence of MIAC and HCA in late PPROM. Protein 
dysregulation was associated with only five cases in the group of 15 women with confirmed MIAC 
and HCA. Altogether, 138 amniotic fluid proteins were changed in these five cases exclusively. 
These proteins were particularly associated with excessive neutrophil responses to infection, such 
as neutrophil degranulation and extracellular trap formation. We believe that the quantification 
of these proteins in amniotic fluid may assist in revealing women with the highest risk of excessive 
inflammatory response in late PPROM.
Preterm prelabour rupture of membranes (PPROM) is defined as leakage of amniotic fluid prior to 37 weeks 
of gestation and the leakage of amniotic fluid happening at least two hours prior to the onset of regular uterine 
 contractions1. Late PPROM, occurring between 34 and 37 weeks of gestation, represents more than 50% of  cases2. 
Despite being considered as “near-term,” late PPROM is associated with significant short-term neonatal morbid-
ity, mainly respiratory distress syndrome and a higher risk of early-onset neonatal  sepsis3. Concerns about the 
long-term consequences have also been raised because children born late preterm are at a higher risk of adverse 
developmental outcomes up to 7 years of  age4,5.
Women with late PPROM can be managed actively with an early planned delivery or expectantly through 
an attempt to prolong the pregnancy. The aim of the active approach is to avoid prolonged fetal exposure to a 
potential intra-amniotic infection. On the other hand, expectant management may reduce the incidence of 
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neonatal morbidity (especially respiratory distress syndrome) as the neonates are more  matured6. A recent meta-
analysis did not reveal evidence of a higher incidence of early-onset neonatal sepsis in the group with expectant 
 management7. In addition, neonates in the active-management group were more prone to develop the respira-
tory distress  syndrome7. The authors therefore suggest that expectant management is an acceptable alternative 
to immediate delivery even in the near-term pregnancy.
Nonetheless, expectant management for all women is still controversial and most national guidelines recom-
mend planned delivery for PPROM shortly after 34 weeks of  gestation8,9. The main rationale for the guidelines 
is the possible presence of subclinical complications such as microbial invasion of the amniotic cavity (MIAC) 
and intra-amniotic inflammation such as acute histological chorioamnionitis (HCA). These complications are 
related to the highest incidence of fetal inflammatory response syndrome and short-term neonatal  morbidity10–12. 
Moreover, MIAC and HCA are frequently asymptomatic and therefore difficult to being detected. The current 
dilemma with the delivery timing suggests that a universal approach may not offer an apparent benefit in all 
cases. Early identification of cases with intra-amniotic and intrauterine complications and personalized clinical 
management might improve the outcomes of late PPROM pregnancies.
Our group has previously shown that the presence of both MIAC and HCA in women with late PPROM 
was associated with an increase of amniotic fluid interleukin-6 (IL-6) in comparison with women with either 
HCA alone, MIAC alone or with absence of both  conditions13. However, little is known about the intra-amniotic 
environment in terms of other proteins, when MIAC and HCA are present in late PPROM. Moreover, the con-
centration of amniotic fluid IL-6 in the presence of MIAC and HCA may vary from hundreds to hundreds of 
thousands pg/mL14. Thus, the heterogeneity of individual cases may hamper proper assessment of how severe 
the intra-amniotic inflammation is.
Despite these facts, a complex proteomic study focused solely on late PPROM is lacking. Liquid chroma-
tography separation coupled to tandem mass spectrometry (LC–MS/MS) enables identification of thousands 
of proteins in different kinds of biological  samples15. One of the main and widely used approaches of protein 
quantification is multiplexed isobaric tagging allowing simultaneous protein quantification in multiple samples. 
In this approach, peptides processed from previous protein digestion are labeled with a chemical tag (reporter) 
in each sample. Differently-labeled samples are then combined before LC–MS/MS analysis. The fragmentation of 
peptide precursors separates the reporter. Subsequently, the difference in peptide level among samples is assessed 
according to the relative abundance of reporters in the fragmentation  spectra16. Finally, protein quantification is 
based on the relative quantification of tagged peptides, unique to identified proteins (Fig. 1A).
The aim of this study was to take advantage of the modern methodology to assess how the amniotic fluid 
proteome responds to the presence of MIAC and/or HCA in women with late PPROM. We believed that these 
findings might improve our understanding of the molecular processes taking place due to MIAC and HCA in 
late PPROM pregnancies, and hence facilitate personalized clinical management.
Methods
Reagents and Material. Unless otherwise indicated, chemicals and reagents were purchased from Sigma-
Aldrich (St. Louis, MO, USA) in the highest available grade.
Ethical approval. This study was approved by the Institutional Review Board—Ethics Committee, Univer-
sity Hospital Hradec Kralove (March 19, 2008, No. 200804 SO1P; and July 2014, No. 201407 S14P). All research 
was performed in accordance with relevant guidelines and regulations. Informed consent was obtained from all 
participants.
Design of late PPROM cohort. The late PPROM cohort was completed considering the following criteria 
as described  previously17. A total of 60 samples of amniotic fluid were collected by transabdominal amniocen-
tesis. Women older than 18 years with a singleton pregnancy, with gestational age between 34 and 37th week, 
and admitted with a diagnosis of PPROM were included. The diagnosis of PPROM was conditioned by pooling 
of amniotic fluid in the vagina and detection of insulin-like growth factor-binding protein 1 (ACTIM PROM 
test; MedixBiochemica, Kauniainen, Finland) in the vaginal fluid. Pregnancy complications such as intrauterine 
growth restriction, structural malformation or chromosomal abnormality of the fetus, maternal hypertension, 
diabetes mellitus, pre-eclampsia, thyroid disease, vaginal bleeding, and fetal hypoxia were exclusion criteria. 
All clinical characteristics are listed in Table 1. Potential differences among the subgroups of late PPROM were 
tested by nonparametric Kruskal–Wallis test for continuous variables and are presented in Table 1 as median 
with interquartile range. Categorical variables were compared by the χ2 test and are presented as numbers (%).
Diagnosis of MIAC and HCA. MIAC was established based on a qPCR detection of Ureaplasma spp., 
Mycoplasma hominis, Chlamydia trachomatis, and positivity for bacterial DNA identified by PCR targeting 16S 
rRNA and analyzed by sequencing, and aerobic/anaerobic culture of amniotic fluid. Detection of DNA of Urea-
plasma spp., M. hominis, C. trachomatis and other bacteria and aerobic and anaerobic cultures of amniotic fluid 
was carried out as in previously published  work18. HCA was diagnosed on the basis of the degree of neutrophil 
infiltration that was inspected separately in the amnion, chorion-decidua, chorionic plate, and umbilical cord. 
The degree of infiltration was assessed according to the criteria described by  Salafia19. A diagnosis of HCA was 
conditioned by the grades of infiltration 3–4 for the chorion-decidua, 3–4 for the chorionic plate, 1–4 for the 
umbilical cord, and/or 1–4 for the amnion. Samples were divided according to the MIAC and HCA status and 
were distributed into four subgroups: subgroup with the presence of both MIAC and HCA, subgroup with MIAC 
alone, subgroup with HCA alone, and subgroup with absence of both MIAC and HCA (Table 1).
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Figure 1.  (A) Multiplex labeling strategy. Four subgroups of amniotic fluid samples were collected: MIAC 
and HCA both present, MIAC present alone, HCA present alone, without MIAC and HCA. An aliquot of 
each sample was taken, and the aliquots were pooled to prepare a global internal standard (GIS). After protein 
digestion, amniotic fluid samples (n = 60) and GIS were labeled with ten isobaric mass tags (126–131). Nine 
differently labeled samples and one labeled GIS aliquot formed one multiplex. In total, seven multiplexes were 
analyzed by different LC–MS/MS experiments. In MS spectra, peptides derivatized with different isotopic 
tags are present as a single peak with the same value of m/z and retention time. The fragmentation of peptide 
precursors separates the reporter ions and fragment ions. The difference in peptide level among individual 
samples is assessed according to the relative intensity of reporter ions in MS/MS spectra. The fragment ions, 
mostly b- and y-, are used for peptide identification. The schematic illustration of late PPROM cohort was 
created with BioRender.com. (B) Normalization of individual samples to the global internal standard and 
removal of proteins with a high number of missing values. The intensities of mass reporter ions were divided by 
the mass reporter intensity of GIS quantified in the same MS/MS spectrum and the ratios were compared across 
defined late PPROM subgroups. Proteins with more than one missing value from three technical replicates in 
more than eight samples were excluded from the final dataset.
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Amniotic fluid sample preparation. Amniotic fluid samples were prepared according to the workflow 
successfully applied in our previous  reports17,20. Briefly, ultrasound-guided transabdominal amniocentesis was 
carried out upon admission before the administration of corticosteroids, antibiotics (penicillin G, clindamycin, 
azithromycin, or clarithromycin), or tocolytics. Up to five mL of amniotic fluid was supplemented with a pro-
tease inhibitor cocktail (Complete Mini, EDTA free, Roche Diagnostics, Basel, Switzerland). The treated samples 
were then centrifuged at 300 × g for 15 min and passed through a 0.22 μm syringe filter (TPP, Trasadingen, Swit-
zerland) to remove cells and debris. The total protein concentration was determined by Bicinchoninic acid assay 
and ballast proteins were removed as described in the Supplementary Document.
Protein digestion. Enzymatic digestion of proteins was processed in 200 mM triethylammonium bicarbo-
nate buffer, pH 8.5 (TEAB, Thermo Scientific, Rockford, IL, USA) with 1% of sodium deoxycholate. Disulfide 
bonds were reduced with 5 mM tris(2-carboxyethyl) phosphine hydrochloride at 60 °C for 1 hour (h), and the 
free thiol groups were blocked using 10 mM methyl methanethiosulfonate at room temperature for 30 min. 
Amniotic fluid proteins were digested with lysyl endopeptidase (Waco Pure Chemical Industries, Osaka, Japan) 
at 37 °C for 4 h, followed by digestion with trypsin (Promega, Madison, WI, USA) at 37 °C overnight. Both 
enzymes were added at a 1:50 enzyme to protein ratio (w/w).
Tandem Mass Tag 10plex isobaric labeling and multiplex strategy. Tandem Mass Tag (TMT) 
10plex isobaric label reagents (Thermo Scientific, Rockford, IL, USA) were dissolved according to the manu-
facturer’s instructions. All the amniotic fluid samples were evaporated to dryness and re-suspended in 8.57 µL 
of 100 mM TEAB, and 1.57 µL was taken from each sample and combined to prepare a global internal standard 
(GIS). The total volume of the GIS was split into 10 aliquots. Individually digested samples and the GIS aliquots, 
both at concentration 1 µg/µL, were incubated with 10 μL of the TMT reagents at room temperature for 1 h. The 
Table 1.  Clinical characteristics of the late PPROM cohort. Clinical characteristics of the women with 
PPROM before 37th week of gestation stratified according to the presence of MIAC and/or HCA. Continuous 
variables were compared using a nonparametric Kruskal–Wallis test. Categorical variables were compared 
using the χ2 test. Continuous variables are presented as median with interquartile range (IQR) and categorical 
as number (%). The statistically significant results are marked in bold. Abbreviations: BMI—Body Mass Index, 
PPROM—preterm prelabor rupture of membranes, MIAC—microbial invasion of the amniotic cavity, HCA—
histological chorioamnionitis, CRP—C-reactive protein, WBC—white blood cells.
MIAC and HCA (n = 15) MIAC alone (n = 15) HCA alone (n = 15)
without MIAC and HCA 
(n = 15) p
Maternal age 31 (26–37) 31 (25–33) 33 (28–36) 33 (31–36) 0.13
Primiparous 7 (47%) 7 (47%) 10 (67%) 4 (27%) 0.19
Prepregnancy BMI [kg/
m2] 22.5 (20.5–24.8) 23.4 (20.2–25.5) 25.0 (22.7–28.9) 24.8 (21.2–27.9) 0.15
Smoking 3 (20%) 4 (27%) 1 (7%) 0 (0%) 0.12
Gestational age at admis-
sion [weeks] 35 + 0 (34 + 0–35 + 5) 35 + 5 (34 + 3–36 + 2) 35 + 1(34 + 6–36 + 0) 35 + 5 (35 + 0–36 + 4) 0.46
Gestational age at deliv-
ery [weeks] 35 + 1 (34 + 4–35 + 5) 35 + 5 (34 + 4–36 + 3) 35 + 6 (35 + 0–36 + 0) 35 + 6 (35 + 0–36 + 4) 0.44
Latency from PPROM to 
amniocentesis [h] 7 (4–11)* 4 (3–7) 6 (3–8) 3 (2–6)* 0.04
Latency from amniocen-
tesis to delivery [h] 10 (4–28) 6 (3–21) 18 (3–40) 9 (3–14) 0.40
Latency from PPROM to 
delivery [h] 24 (11–31) 13 (6–28) 25 (12–48) 12 (9–20) 0.15
CRP levels at admission 
[mg/L] 6.0 (3.2–22.2) 5.0 (3.7–10.0) 6.8 (4.2–10.9) 4.6 (1.7–10.2) 0.49
WBC count at admission 
[× 109 L] 13.7 (10.8–14.4) 11.5 (9.6–13.2) 10.6 (9.2–11.4) 11.8 (9.1–13.4) 0.09
Administration of 
antibiotics 15 (100%) 13 (87%) 13 (87%) 15 (100%) 0.23
Administration of corti-
costeroids 5 (33%) 3 (20%) 2 (13%) 2 (13%) 0.48
Spontaneous vaginal 
delivery 12 (80%) 14 (93%) 12 (80%) 10 (67%) 0.34
Forceps delivery 0 (0%) 0 (0%) 0 (0%) 1 (7%) 0.38
Cesarean delivery 3 (20%) 1 (7%) 3 (20%) 4 (27%) 0.55
Birth weight [g] 2750 (2300–2900) 2310 (1940–2860) 2590 (2300–2950) 2610 (2300–2980) 0.35
Apgar score in 5 min 10 (9–10) 10 (9–10) 10 (9–10) 10 (9–10) 0.69
Apgar score in 10 min 10 (10–10) 10 (10–10) 10 (10–10) 10 (10–10) 0.87
Funisitis 9 (60%) 0 (0%) 5 (30%) 0 (0%)  < 0.001
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reaction was terminated by adding 5% hydroxylamine. Nine amniotic fluid samples and one GIS aliquot were 
mixed in 1:1 ratio to create seven multiplexes (Fig. 1A). To complete the seventh multiplex, the last three GIS 
aliquots were labeled by 126, 128C, 129C channels. However, these labeled GIS aliquots were not considered in 
the data evaluation. Prepared multiplexes were cleaned by peptide extraction on solid phase as described in the 
Supplementary Document.
Liquid chromatography coupled to tandem mass spectrometry (LC–MS/MS). The multiplexes 
were redissolved in 0.1% trifluoroacetic acid (TFA), 2% acetonitrile (AcN) to a concentration of 1 µg/µL and 
injected twice on an UltiMate 3000 RSLCnano System (Thermo Scientific, Bremen, Germany) in three technical 
replicates. The analytical system consisted of a PepMap100 C18, 3 µm, 100 Å, 75 µm × 20 mm trap column and 
a PepMap RSLC C18, 2 µm, 100 Å, 75 µm × 500 mm analytical column (both from Thermo Scientific, Bremen, 
Germany) and was previously used in our proteomic  analyses21. The samples were loaded onto the trap column 
at a flow rate 8 µl/min of 0.1% TFA, 2% AcN for 3 min. Tryptic peptides were separated via a linear gradient 
running from 2 to 45% of 0.1% formic acid, 80% AcN at a flow rate 200 nL/min for 240 min. Eluted peptides 
were sprayed into a Q Exactive Plus mass spectrometer using a Nanospray Flex ion source (Thermo Scientific, 
Bremen, Germany) at 1.8 kV spray voltage. Positive ion full scan MS spectra were acquired in the range of m/z 
350–1600, with 3 × 106 AGC target in the Orbitrap at 70,000 resolution with a maximum ion time of 50 ms. A 
lock mass of m/z 445.12003  ([C2H6SiO]6) was used for internal calibration of the mass spectra. The fragmenta-
tion (MS/MS) spectra were acquired for the 15 most intense precursors. Other parameter settings were assumed 
from the  literature22. Isolation window of 1.2 m/z and normalized collision energy of 33 was used. Each frag-
mentation spectrum was acquired at a resolution of 35,000, with a 2 × 105 AGC target and a maximum injection 
time of 100 ms. The first mass was fixed to 120 m/z.
Data treatment. Recorded spectra were processed and searched in MaxQuant 1.5.5.1 against a reviewed 
SwissProt human protein database including contaminants downloaded in 2016. Trypsin digestion specificity 
with up to two missed cleavages allowed was used. Cysteine thiomethylation was set as a fixed modification and 
oxidation of methionine was selected as a variable modification. The mass tolerance in MS and MS/MS mode 
was left at the default value for the initial search and 6 ppm was set as mass tolerance in MS mode for the main 
search. The false discovery rate for protein identification was left at the default value. Output files from Max-
Quant were processed in  Perseus23 and  R24. Potential contaminants and proteins identified by site and by reverse 
sequence were removed. The reporter intensity of proteins in each sample was divided by reporter intensity of 
proteins in the GIS, both adjusted to correction factors. Resulting ratios were  log2 transformed and normalized 
to the median. One-way analysis of variance (ANOVA) with Benjamin–Hochberg false discovery rate (FDR) 
correction was applied to compare normalized protein ratios in the subgroups of late PPROM. Perseus Tukey’s 
significant honest difference post-hoc test on the significance level of 0.05 was used on the ANOVA significant 
hits. Gene ontology (GO) analysis was carried out using StringApp  plugin25 in the Cytoscape  platform26 (enrich-
ment p value < 0.01). Violin plots, principal component analysis (PCA) plot and bubble plots were designed in 
the R software. Bar graphs of GO terms were prepared in GraphPad Prism 6.
Amniotic fluid IL-6 and histone H1.5 level determination by ELISA. ELISA kit for human IL-6 
(R&D systems, MN, USA) and human histone H1.5 (MyBiosource, CA, USA) were used to determine IL-6 and 
H1.5 levels in amniotic fluid. Samples with IL-6 concentration above the top calibration point were diluted to fit 
the calibration range. Resulting absorbance was read at 450 nm with correction to 540 nm. Data was evaluated 
in GraphPad Prism 6.
Results
Clinical characteristics of the patient cohort. A late PPROM cohort of 60 amniotic fluid samples with 
the presence or absence of MIAC and/or HCA was designed (Fig. 1A) and important clinical characteristics 
were compared among the subgroups (Table 1). Gestational age at delivery was considered as important clinical 
confounder of protein level due to a substantial increase in protein turnover during  pregnancy27. Hence, the late 
PPROM cohort was carefully designed to include women in similar gestational age at admission and delivery. 
The median time of latency between late PPROM and amniocentesis was 4 h. We found a significant difference 
only between the subgroup with the presence of both MIAC and HCA (median = 7 h; IQR 4–11 h) compared to 
the subgroup with the absence of both MIAC and HCA (median = 3 h; IQR 2–6 h; p = 0.04). The median time of 
latency between amniocentesis and delivery was 10 h and the median time of latency between late PPROM and 
delivery was 16 h. There was not any significant difference in the duration between amniocentesis/late PPROM 
and delivery (p = 0.4 and p = 0.15, respectively). Based on these results, we infer that the changes of protein levels 
were not due to differences in the gestational age.
Tandem Mass Tag 10plex LC–MS/MS analysis and data treatment. The wide dynamic range of 
protein concentration represents a major obstacle in mass spectrometry-based protein analysis in human bio-
logical fluids such as plasma or amniotic fluid. Human serum albumin (HSA) is the most abundant protein in 
amniotic fluid and may smother information on important but far less abundant  proteins28. The immunoaffinity 
depletion of abundant ballast proteins allowed us to detect a total of 1132 amniotic fluid proteins. The protein 
quantity was expressed as the ratio of TMT reporter ion intensity of each identified protein to the TMT reporter 
ion intensity of the global internal standard (GIS) in the respective multiplex (Fig. 1B). This allowed us to deter-
mine protein level changes in all 60 samples by the implementation of ten isobaric tags. Subsequent filtration of 
protein contaminants and proteins with a high number of missing values reduced the dataset to 816 quantified 
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amniotic fluid proteins. Out of those, a total of 716 proteins were quantified in at least two from three technical 
replicates in all samples and 100 proteins were quantified in at least two technical replicates in eight samples 
in each late PPROM group (Fig. 1B). Thus, 72% of the identified proteins were kept for further consideration.
Comparative analysis of amniotic fluid proteins in the presence or absence of MIAC and/or 
HCA. The initial comparison was based on determination of the protein difference in the subgroups divided 
according to MIAC and/or HCA (the presence of both MIAC and HCA, MIAC alone, HCA alone, and the 
absence of both MIAC and HCA). Firstly, the multiple comparisons of protein levels were adjusted by Benjamin-
Hochberg correction with the FDR threshold 0.05. However, no significant protein changes related to MIAC 
and/or HCA were found. The histone H1.5 (H1.5) was found as the first protein above the FDR threshold (FDR 
q value = 0.0625). Thus, violin plots based on the level of H1.5 in amniotic fluid were constructed to explain the 
uniformity of the late PPROM subgroups despite distinct MIAC and HCA status (Fig. 2A). Although the mean 
of the subgroup with the presence of both MIAC and HCA was higher than the mean of other subgroups, we 
observed a distinctly higher variance of the subgroup with the presence of both MIAC and HCA. Subsequently, 
a PCA plot of all individual samples was constructed and all 816 proteins were used as variables (Fig.  2B). 
The PCA plot also showed a distinct distribution of the subgroup with the presence of both MIAC and HCA 
compared to other late PPROM subgroups. The PCA plot illustrating the distribution of all individual samples 
revealed a cluster of five samples from the subgroup with both MIAC and HCA. The distribution of these five 
samples was dissimilar compared to the distribution of the remaining samples in the PCA plot (Fig. 2B). Violin 
and PCA plots together illustrated substantial heterogeneity of protein response to MIAC and HCA and a unique 
subgroup of five women was identified. Thus, we set those five samples as an individual group and conducted a 
subsequent analysis of variance of the following late PPROM subgroups: five outlying samples with the presence 
Figure 2.  (A) Violin plots illustrating the heterogeneity of the subgroup with the presence of both MIAC 
and HCA. The construction of violin plots was based on the level of histone H1.5 in all samples. Subgroup 
with the presence of both MIAC and HCA is highlighted in red. Points with the error bars represent means 
with ± standard deviation. (B) PCA score plot of individual samples. Each point represents one sample. Each 
ellipse represents one late PPROM subgroup. Points and ellipse of the subgroup with the presence of both MIAC 
and HCA are highlighted in red. The position and the size of the ellipses depend on sample distribution in each 
group. The PCA plot shows uniqueness of the five outlying samples in comparison with the other PPROM 
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of both MIAC and HCA, the remaining ten samples with the presence of both MIAC and HCA, MIAC alone, 
HCA alone, or the absence of both MIAC and HCA. We applied the Benjamin-Hochberg correction with the 
FDR threshold 0.01 in this case.
The subsequent comparison by ANOVA and computed Tukey’s honestly significant difference uncovered 
that 138 proteins were significantly up- or downregulated in the five outlying samples compared to all other 
subgroups. In total, 112 proteins were upregulated and 26 proteins were downregulated (Supplementary table). 
To further characterize these proteins and explain the distinction of the five samples from the remaining samples 
with the presence of both MIAC and HCA, we conducted gene ontology analysis using the StringApp  plugin25. 
All over-represented biological processes, cellular localization, and pathway terms are summed on Supplementary 
table and the most significant GO terms are depicted in Fig. 3A. Most of the upregulated proteins were local-
ized in neutrophil granules (Fig. 3B). In terms of neutrophil activity, the protein upregulation was associated 
with platelet activation, glycolysis, the pentose phosphate pathway, and redox processes (Fig. 3C). By contrast, 
downregulated proteins were annotated as regulatory proteins (Fig. 3A).
Correlation of the amniotic fluid proteome with the level of interleukin-6, HCA and 
MIAC. Amniotic fluid IL-6 is currently the most relevant and discussed protein for evidence of intra-amni-
otic inflammation in  PPROM29. Accordingly, we determined also the concentration of IL-6 in our samples and 
examined the correlation of IL-6 with the protein upregulation discovered through TMT 10plex LC–MS/MS 
analysis. We sought to assess whether proteome differences in the presence of MIAC and/or HCA correspond 
with the level of IL-6 in amniotic fluid. To this end, we constructed bubble plots as a correlation of H1.5 level 
with that of two other proteins, neutrophil defensin 3 (DEFA3) and protein S100A12. The size of bubbles are 
set according to the concentration of IL-6 and the color of bubbles represents the presence or absence of HCA 
and funisitis, the most severe form of HCA characterized by the presence of neutrophils in the umbilical cord 
(Fig. 5A,B). Histone H1.5, DEFA3, and S100A12 were found as highly upregulated proteins in the five outlying 
samples with the presence of both MIAC and HCA (Supplementary table). Moreover, DEFA3 and S100A12 were 
classified as proteins enriched in the antimicrobial immune response, neutrophil degranulation, and cell secre-
tion (Fig. 3B). DNA-associated histones are frequently discussed as forming neutrophil extracellular traps upon 
infectious  stimuli30 (Fig. 4).
Amniotic fluid levels of H1.5, DEFA3 and S100A12 showed substantial enhancement in the case of the five 
samples with the presence of both MIAC and HCA and also positive correlation with the highest levels of IL-6 
(Fig. 5). Together, funisitis was confirmed in these five samples (Fig. 5A,B). These five samples were also found 
to have a high microbial load of Ureaplasma spp. and M. hominis DNA (threshold cycle values < 22, responding 
quantity more than  105 copies/mL) or the presence of Haemophilus influenzae and Sneathia sanquinegens was 
confirmed (Fig. 5C,D and Table 2).
Validation of amniotic fluid histone H1.5. As aforementioned, amniotic fluid histone H1.5 level was 
found to be significantly higher in the five samples from the subgroup with the presence of MIAC and HCA 
(Supplementary table). Histone H1.5 is an important intracellular protein related to excessive inflammatory 
 response31. Thus, we determined the amniotic fluid level of histone H1.5 in the subgroups with the presence or 
absence of MIAC and/or HCA using ELISA. All but six samples had the level of H1.5 on concentration below the 
limit of detection of the ELISA kit (Fig. 6). The H1.5 level of the five outlying samples from the subgroup with 
both MIAC and HCA was in the range from 1.44 to 4.56 ng/mL. The sixth sample with H1.5 level of 2.11 ng/mL 
belonged to the group with MIAC alone but the IL-6 level of this sample was more than 15,000 pg/mL despite 
the absence of chorioamnionitis or funisitis (Fig. 6).
Discussion
In this study, we utilized a quantitative proteomic approach based on isobaric labeling of peptides to reveal 
proteome differences related to the MIAC and HCA in women with late PPROM. The principal findings of this 
study are: (1) The levels of amniotic fluid proteins in the subgroup with both MIAC and HCA were surprisingly 
uniform compared to the other late PPROM subgroups where both conditions weren’t confirmed. We found 
only five cases of late PPROM women with a substantial protein dysregulation related to both MIAC and HCA. 
We speculate that particularly these women can profit from an active management beyond the 34th week of 
gestation. (2) Proteome change was associated with a high concentration of IL-6 in amniotic fluid. (3) The posi-
tive correlation of proteomic findings with IL-6 concentration identified five women with strong intra-amniotic 
inflammation in late PPROM.
In our previous reports, LC–MS/MS enabled us to reveal changes in amniotic fluid proteome associated with 
the presence of MIAC and HCA in PPROM from 24 to 36th week of  gestation17,20,32. However, to the best of our 
knowledge, a global proteomic study focused on PPROM beyond the 34th week has not been carried out yet. In 
TMT 10plex-based quantification, peptides of each sample are tagged with one different isotopic variant from a 
set of ten mass  tags16,33. However, since the number of patients in our late PPROM cohort exceeded the number 
of TMT channels, we designed seven multiplexes and analyzed them in different LC–MS/MS runs (Fig. 1A). 
Normalization of mass tag information to the GIS removed the eventual intensity fluctuation during LC–MS/
MS analysis of a particular multiplex, e.g. due to instability of electrospray (Fig. 1B).
Protein abundance may vary by orders of magnitude in complex samples. To make this variance similar across 
the global amniotic fluid proteome, the data were  log2 transformed and normalized to the  median34. Also, a high 
number of missing values may debase mass tag-based quantification and provide incorrect information about 
protein  levels35. Perseus software replaces the missing values by random numbers that are estimated from normal 
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 distributions23, but that would mean working with a dataset containing artificial values. Hence, we rather decided 
to exclude proteins with a high number of missing values in technical replicates of analyzed samples (Fig. 1B).
This study was inspired by published results which indicated that a change of amniotic fluid proteome is 
associated with the presence of both MIAC and HCA in  PPROM20,32. The authors applied a CysTRAQ approach, 
consisting of iTRAQ labeling to quantify selectively the fraction of peptides with cysteine residue and the frac-
tion of non-cysteinyl peptides and found more than 80 amniotic fluid proteins significantly dysregulated in the 
presence of MIAC and HCA in PPROM pregnancies. Histone H4 together with other antimicrobial proteins 
(cathelicidin, neutrophil defensin 1, myeloperoxidase, etc.) and proteins integrated in neutrophil extracellular 
traps (myosin-9, plastin-2, matrix metalloproteinase-9, etc.) were shown to be considerably upregulated in the 
presence of both MIAC and HCA. Besides the CysTRAQ article, recent papers have discussed the elevation of 
IL-6 in the presence of both MIAC and HCA in cases of both PPROM and late  PPROM13,36. The authors also 
concluded that the presence of both MIAC and HCA and a higher level of IL-6 were related to early-onset sepsis 
and neonatal morbidity.
In the CysTRAQ study, a pooled sample strategy was used. The pooling of samples is a time-efficient strategy 
compensating for limited amounts of the samples or high biological  variation37. However, protein inflammatory 
response to MIAC and HCA is not a homogeneous phenomenon and a pooling strategy may disguise the vari-
ance of inflammatory protein concentration in individual samples. Keeping in mind the heterogeneity of MIAC 
and HCA, we required information about levels of proteins in each individual sample of the patient cohort. 
Moreover, we included also the subgroups with MIAC alone and HCA alone. Histological chorioamnionitis itself 
may evoke the pro-inflammatory protein response, but only the presence of both MIAC and HCA is apparently 
related to a higher number of cases of early-onset sepsis and fetal inflammatory response  syndrome13,38. Hence, 
it is desirable to distinguish women with both MIAC and HCA from those with HCA alone.
Analysis of data achieved through TMT 10plex LC–MS/MS and correlation of these data with the IL-6 con-
centration in amniotic fluid, diagnosed funisitis, and MIAC revealed the substantial disparity in the subgroup 
with the presence of both MIAC and HCA. Dysregulation of amniotic fluid proteins occurred only in five cases 
in the subgroup with the presence of both MIAC and HCA whereas no significant distinction of protein level 
was observed in the remaining 55 entities regardless of MIAC and/or HCA (Fig. 2). These five samples were 
also affected by a high DNA load of Ureaplasma spp. and/or M. hominis and/or the presence of Haemophilus 
influenzae and Sneathia sanquinegens (Fig. 5C,D, Table 2). Nevertheless, some of the samples from women with 
MIAC alone with a low level of protein determined by LC–MS/MS as well as a low level of IL-6 were also affected 
by a high load of bacterial DNA (Fig. 5C,D). This confirmed previous findings that MIAC can occur as isolated 
bacterial colonization without any inflammation-associated change of  proteome2. These five “outliers” were also 
diagnosed as pregnancies with funisitis (Fig. 5A,B). Funisitis is defined as the presence of neutrophils in the wall 
of umbilical vessels and/or Wharton’s  jelly39. It seems that these five cases of the subgroup with both MIAC and 
HCA are the most affected cases with potential severe fetal inflammatory involvement.
A total of 138 proteins were significantly up- or downregulated in the five samples of the group with the pres-
ence of both MIAC and HCA compared to the other samples from women with late PPROM (Supplementary 
table). Substantial portion of upregulated proteins was annotated as secreted proteins present in neutrophil 
granules, proteins participating in glycolysis and the pentose phosphate pathway, in the regulation of cytoskeletal 
actin, and redox process (Fig. 3). The downregulated proteins were classified as regulators of acute inflammatory 
response. Neutrophil degranulation and secretion is host defense mechanism against potential intra-amniotic 
Figure 3.  (A) Gene ontology analysis of 138 proteins found as significantly changed in the five outlying samples 
with the presence of both MIAC and HCA. The most over-represented terms of cellular localization, biological 
process, and pathways are depicted. The FDR p value threshold of 0.01 is marked. The gene-ontology terms were 
retrieved from the STRING enrichment web service using the StringApp in the Cytoscape 3.6.0 (https ://cytos 
cape.org/). (B) Change of neutrophil granular proteins. Many of the proteins present in neutrophil granules 
were found to be significantly up (red arrow) or downregulated (blue arrow) in the five outlying samples 
with the presence of both MIAC and HCA. (C) The upregulation of enzymes participating in glycolysis, the 
pentose phosphate pathway and redox processes. Upregulation of enzymes participating in the main metabolic 
neutrophil pathways (glycolysis and pentose phosphate pathway) and killing mechanisms related to neutrophil 
extracellular traps (redox processes) are depicted (red arrows). The illustration of neutrophil degranulation 
was created with BioRender.com. Abbreviations: A1BG—alpha-1B-glycoprotein; ACTN1—alpha actinin 1; 
ACTN4—alpha actinin 4; ALDOA—aldolase; ANXA3—annexin A3; CAMP—cathelicidin; CAP1—adenylyl 
cyclase-associated protein 1; CAT—catalase; CDA—cytidine deaminase; CHI3L1—chitinase-3-like protein 
1; COTL1—coactosin-like protein; CTSC—dipeptidyl peptidase 1; CTSD—cathepsin D; CTSS—cathepsin 
S; DEFA3—neutrophil defensin 3; ECM1—extracellular matrix protein 1; ENO1—alpha-enolase; FGB—
fibrinogen; GDI2—Rab GDP dissociation inhibitor beta; GLRx—glutaredoxin; GPI—glucose-6-phosphate 
isomerase; HSPA8—heat shock cognate 71 kDa protein; HSP90AA1—heat shock protein HSP 90-alpha; 
IQGAP1—ras GTPase-activating-like protein IQGAP1; MMP9—matrix metalloproteinase-9; MPO—
myeloperoxidase; LCN2—neutrophil gelatinase-associated lipocalin; LDHA—L-lactate dehydrogenase A chain; 
LDHB—L-lactate dehydrogenase B chain; PGAM1—phosphoglycerate mutase 1; PGD—6-phosphogluconate 
dehydrogenase; PGK1—phosphoglycerate kinase 1; PGLRYP1—peptidoglycan recognition protein 1; PKM—
pyruvate kinase; PPIA—peptidyl-prolyl cis–trans isomerase A; PRDX1—peroxiredoxin 1; S100A11—protein 
S100A11; S100A12—protein S100A12; S100P—protein S100P; SEPP1—selenoprotein P; SERPINB1—leukocyte 
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 infection40. Upon cell activation, antimicrobial proteins such as myeloperoxidase (MPO), DEFA3, cathelicidin 
are released from neutrophil  granules20,41. The lumen of neutrophil granules was the most over-represented cel-
lular component in our GO analysis (Fig. 3A).
Besides the granular proteins mentioned above, we found other 34 proteins present in neutrophil granules 
and most of them were highly upregulated in the five discussed samples (Fig. 3B). Upregulated calcium-binding 
S100 proteins are small secreted proteins crucial for neutrophil migration and they may act as alarmins in the 
pathology of funisitis and early neonatal  sepsis42. In addition, protein S100-A12 has a function as a ligand for 
the receptor for advanced glycation end‐products (RAGE)43. The ligand-RAGE interplay is a key mechanism 
of reactive oxygen species (ROS) generation and oxidative  burst44. Other target molecule of S100 proteins is 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a key enzyme of  glycolysis45. Glycolysis and the pentose 
phosphate pathway (PPP) are the key metabolic pathways in neutrophils and we found both of them as signifi-
cant pathways in GO enrichment (Fig. 3A). We observed an expressive upregulation of enzymes participating 
in glycolysis and pyruvate generation in the five samples of the subgroup with the presence of both MIAC and 
HCA (Fig. 3C).
Besides energy generation, glycolysis and PPP directly affect also the formation of ROS by providing NADPH. 
A total of 19 proteins related to the redox process were upregulated in the five samples. We found upregula-
tion of enzymes important for formation and elimination of ROS, including MPO, mitochondrial superoxide 
dismutase, catalase, glutaredoxin-1, peroxiredoxin-1, etc. (Supplementary table, Fig. 3C). Glycolysis, PPP and 
MPO- induced ROS may directly affect releasing of neutrophil extracellular traps (NETs)46–48. The presence of 
NETs in intra-amniotic infection and inflammation has been already  established49. Unambiguous confirmation 
of NETs in amniotic fluid for instance using immunofluorescence  microscopy50 was beyond the scope of this 
study. Nevertheless, we found alterations in the redox homeostasis affecting the neutrophil activity towards to 
NETs formation as well as the substantial upregulation of proteins being a part of NETs defense mechanisms 
such as MPO, DEFA3, MMP9 and histone isoforms representing strong indicia of the NETs presence (Fig. 4)51.
Histones are frequently discussed as key part of NETs and potential biomarkers of MIAC and HCA in 
 PPROM20,32,49. In the five outlying samples from the subgroup with both MIAC and HCA, histones H1.5, H2B, 
H4 and H3.2 were highly upregulated. The level of H1.5 in amniotic fluid determined by ELISA also showed a sig-
nificant increase in the five outlying samples with the presence of both MIAC and HCA compared to the other 55 
samples (Fig. 6). Beyond the direct antimicrobial function, extracellular histones in released NETs bind platelets 
and induce platelet  aggregation52. NETs have been even signed as a link between inflammation and  thrombosis53. 
We found twenty up- or downregulated proteins related to platelet activation, signaling and aggregation (Fig. 3A, 
Supplementary table). From those, cofilin-1 and actinins were the most upregulated. Cofilin-1 is an actin-binding 
protein responsible for actin re-modelling preceding platelet  aggregation54,55. On the other hand, another platelet 
protein thrombospondin-1 was downregulated in the five outlying samples with the presence of both MIAC 
and HCA compared to the other 55 samples. Thrombospondin-1 inhibits the activity of neutrophil elastase and 
cathepsin G and mitigates the inflammatory  response56. We suggest that downregulation of thrombospondin-1 
may promote the activity of neutrophil proteases as a consequence of excessive intra-amniotic inflammation in 
the specific subgroup with the presence of both MIAC and HCA in late PPROM.
Figure 4.  Neutrophil extracellular trap formation. The proteins contributing to the formation of neutrophil 
extracellular traps and upregulated in the five outlying samples with the presence of both MIAC and HCA 
are depicted with a red arrow. The illustration of neutrophil extracellular traps was created with BioRender.
com. Abbreviations: ACTG1—actin; DEFA3—neutrophil defensin 3; HIST1H1B—histone H1.5; HIST1H4A—
histone H4; HIST2H2BM—histone H2B type 1-M; HIST2H3A—histone H3.2; HIST2H2BE—histone H2B type 
2-E; LCP1—plastin 2; MPO—myeloperoxidase; MYH9—myosin 9.
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Conclusion
In this study, we analyzed a unique collection of late PPROM amniotic fluid samples without a significant differ-
ence in gestational age at PPROM, amniocentesis, and delivery. We revealed the dysregulation of 138 proteins 
along with the high level of amniotic fluid IL-6, the presence of funisitis and MIAC. This study was initially 
aimed at discovery of protein changes associated with MIAC and HCA. We had presumed that the presence of 
neutrophils in the placenta, umbilical cord, and fetal membranes would be reflected by the change in the amni-
otic fluid proteome. However, we only detected five samples in the subgroup with the presence of both MIAC 
and HCA with substantial change in proteome composition. Consequently, the original stratification of the late 
PPROM cohort based on the status of HCA turned out to be a limitation of this study because the number of 
Figure 5.  Correlation of the proteomic results with amniotic fluid IL-6 level determined by ELISA, the presence 
of funisitis, chorioamnionitis and intra-amniotic infection. Amniotic fluid relative quantity of histone H1.5 
together with defensin 3 (DEFA3) and protein S100A12 (S100A12) were put into the correlation in the bubble 
plot. The size of points was set according to the level of IL-6 and the color of points represents the presence of 
HCA (blue) and funisitis (red) (A, B). The green-coloured points represent samples with the highest quantity of 
microbial invasion and/or the presence of Haemophilus influenzae and Sneathia sanquinegens (C, D). The five 
outlying samples were labelled by identification code (P letter and number).
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MIAC/HCA women with a strong proteome response was very low. However, these women can particularly 
profit from active management compared to other women with late PPROM. With respect to the achieved 
results, we recommend diagnosing the intra-amniotic inflammation rather based on the level of amniotic fluid 
IL-6 than as the diagnosed HCA. Nevertheless, the threshold values of intra-amniotic inflammation in PPROM 
vary from 2.6 to 11.3 ng/mL in previous  publications57, and the conclusive cut-off value has not been established. 
Future research should thus unambiguously define the concentration of IL-6 representing the threshold for the 
confirmation of intra-amniotic inflammation.
Data availability
The mass spectrometry data together with the MaxQuant output files have been deposited in the ProteomeX-
change Consortium via the PRIDE  partner58 repository with the dataset identifier PXD020329.
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